The antifolate drug combination pyrimethamine-sulfadoxine 1990, a single dose of pyrimethamine-sulfadoxine was used successfully in children in the area to clear parasitemia for up has become the treatment of choice for uncomplicated falciparum malaria in parts of east and southern Africa, where chloto 4 weeks, after which the impact of vector control on malaria incidence was assessed [4] . However, in January 1995, 50% roquine resistance is widespread. Recent data from a holoendemic area in northeast Tanzania suggest that resistance to this of treated children showed recurrence of parasitemia 3 weeks after pyrimethamine-sulfadoxine treatment, and subsequently, drug combination has developed there recently [1 -3] . In 1988 -an alternative antifolate combination, chlorproguanil-dapsone, was tested in a comparative trial with pyrimethamine-sulfadoxine [3] . There were significantly fewer parasitemic children in mM each primer, 1% Tween 20, and 1 U of Taq polymerase dium falciparum [8 -11] and samples from malaria patients (Bioline, London) in a volume of 50 mL. The DNA template was [12, 13] . A preliminary survey of some of these blood samples a small piece of washed glass fiber membrane containing the blood showed that Asn at position 108 of DHFR, a variant that has sample [14] . The PCR program used was 1 cycle of 94ЊC for 3 been associated with in vitro resistance to pyrimethamine and min; 40 cycles of 94ЊC for 1 min, 50ЊC for 2 min, and 72ЊC for cycloguanil (the active metabolite of proguanil), was selected 2 min; and a final 72ЊC for 10 min.
in vivo by treatment with either drug combination [14] Restriction sites for some enzymes in nonpolymorphic regions Services, Coulsden, UK), on 3 successive days. They were collected of the amplified fragments acted as internal controls for digestion. by fingerprick directly onto filter paper-glass fiber disks as previously Fragment M3-F/ contained an NlaIII control site, six Tsp509I condescribed [14] . The samples were sent by airmail to London, where trol sites, and two DraI controls. Fragment F-M4 contained an they were processed for use in PCR [14] .
XmnI control site, and fragment K-K/ contained an MnlI control.
Polymerase chain reactions. A 648-bp fragment of the dhfr gene
Other control sites were created by mismatches in the primers: was amplified with primers M1 (5-TTTATGATGGAACAAGTCAluI in M4, FokI in K, MwoI in K/, and BstUI in L/. TGC-3) and M5 (5-AGTATATACATCGCTAACAGA-3). The
Restriction enzyme digestion was done under the conditions amplified product was further amplified in two separate nest 2 reacspecified by the suppliers (New England BioLabs, Hitchen, UK). tions with either M3 (5-TTTATGATGGAACAAGTCTGCGAC-
The appropriate amplified fragments of DNA from standard strains GTT-3) and F/ (5-AAATTCTTGATAAACAACGGAaccof P. falciparum were used as positive and negative controls in TttTA-3) (lower case bases are mismatches, see below), giving a each batch of digestion. Products of digestion were separated on 522-bp fragment containing all five polymorphic residues, or F 1.5%-3% gels containing 2:1 agarose (Ultrapure; Life Technolo-(5-GAAATGTAATTCCCTAGATATGgAATATT-3) and M4 gies, Paisley, UK) to agarose (Nuseive GTG; FMC BioProducts, (5-TTAATTTCCCAAGTAAAACTATTAGAgCTTC-3), giving Rockland, ME). a 326-bp fragment containing residues 59 and 108.
Sequencing. A novel variant at position 436 of DHPS was A 711-bp fragment of the dhps gene was amplified with primers identified by sequencing a fragment of a nest 2 PCR product, R2-R2 (5-AACCTAAACGTGCTGTTCAA-3) and R/ (5-AAT-K/. The fragment was sequenced in both directions by using R2 TGTGTGATTTGTCCACAA-3). The amplified product was furas the sense primer or an internal antisense primer S/ (5-TATther amplified in each of three nest 2 reactions. Primers K (5-AGTTAATTGTATCAATACTT-3), a thermosequenase dye terTGCTAGTGTTATAGATATAGGatGAGcATC-3) and K/ (5-minator cycle-sequencing kit (Amersham Life Science, Little ChalCTATAACGAGGTATTgCATTTAATgCAAGAA-3) amplified font, UK), and analysis on a DNA sequencer (ABI Prism 377; a 438-bp fragment for identification of variants at positions 436
Perkin-Elmer, Foster City, CA treatment with either pyrimethamine-sulfadoxine or chlorproDiscussion guanil-dapsone. Infections were polyclonal, and some samples Previously, we have demonstrated selection by chlorproguacontained a mixture of parasite clones with different variants nil-dapsone or pyrimethamine-sulfadoxine treatment of the in individual DHPS residues. Positions 436, 437, and 540 of Asn 108 variant of DHFR [14] , which has been associated with DHPS were polymorphic before treatment. Restriction enzyme in vitro resistance to pyrimethamine and cycloguanil [8, 9, 12]. digestion indicated that there was an unknown variant at posiIn the present survey, it was shown that in addition to selection tion 436 present in 4 samples, which was identified by sequencfor Asn 108 , the variants Ile 51 and Arg 59 of DHFR, which confer ing as TGT (cysteine). All but 1 of the analyzed samples colincreased resistance to pyrimethamine in parasites with Asn 108 lected 3 weeks after pyrimethamine-sulfadoxine treatment [8, 9], were also selected by both drug combinations. There contained parasites carrying only Ser 436 , Gly 437 , and Glu 540 in are no data on the molecular basis of resistance to chlorcyclogu-DHPS. The highly significant reduction in prevalence of Ala 436 , anil, the active metabolite of chlorproguanil, but data on the Ala 437 , and Lys 540 after pyrimethamine-sulfadoxine treatment structurally closely related compound cycloguanil showed that indicated strong selection against these variants. However, their strains with high resistance to both pyrimethamine and cycloprevalences after chlorproguanil-dapsone treatment were not guanil carried Asn 108 and one or both of the Ile 51 and Arg 59 significantly different from their prevalences before. The DHPS variants [8, 9] . genotype Ser 436 , Gly 437 , and Glu 540 was present in 7 of 30
Chlorproguanil-dapsone treatment did not select for any of samples before treatment, 21 of 21 samples after pyrimeththe known variants of DHPS present in the local population of amine-sulfadoxine treatment (P õ .001), and 9 of 24 samples P. falciparum. In contrast, the DHPS genotype Ser 436 , Gly 437 , after chlorproguanil-dapsone treatment (not significantly differGlu 540 was selected by pyrimethamine-sulfadoxine treatment. ent from the prevalence before treatment).
A possible explanation for this difference is that resistance to Positions 51, 59, and 108 of DHFR were polymorphic before dapsone involves changes in other, untested, residues of DHPS treatment (table 2). Samples collected 3 weeks after treatment because of the structural differences between sulfadoxine and with either drug combination contained parasites with only Ile 51 dapsone. However, we favor the hypothesis that the difference and Asn 108 , and 48 samples of 52 contained parasites with only in selection is related more to the pharmacokinetics of the drug Arg 59 . There was significant selection against Asn 51 , Cys 59 , combinations. and Ser 108 by both drug combinations. The Thr 108 variant, which
There is high malaria transmission in the area where the has been described in strains with in vitro resistance to cyclodrug study was done, with a reinfection rate of 20% per week guanil but sensitivity to pyrimethamine [8, 9], was absent from [4] . Superinfection occurs, with concomitant infections in the all 82 tested samples.
blood and liver. The parasites in the blood at 3 weeks may There was no association between DHFR or DHPS variants have been present at treatment either in the blood or in the present in infections at the time of treatment in individual liver, from which they emerged later, or may have resulted from new mosquito bites. Pyrimethamine-sulfadoxine, because children and their subsequent parasitologic responses. Antigen-specific cellular immune responses were examined in persons previously infected with Schistosoma haematobium and who were, 2 years after chemotherapy, either free from infection (n Å 17) or reinfected (n Å 20). Proliferation to adult worm antigen (AWA) was significantly higher in uninfected than in reinfected subjects (P Å .02), whereas responses to soluble egg antigen (SEA) remained low in both groups. Interleukin (IL)-5 production in uninfected persons in response to AWA and SEA was higher than in infected subjects (P Å .05 and P õ .001, respectively), while IL-4 and IL-13 release was similar in the 2 groups. Levels of interferon-g to AWA and to SEA were inversely correlated with egg output (P Å .03 and P Å .02, respectively). These data indicate that the presence of schistosome infection leads to T cell proliferative hyporesponsiveness and that both typical Th1 and Th2 cytokines can be down-regulated by active infection.
In schistosomiasis, immunoepidemiologic studies have esSuperimposed on the genetic predisposition to infection is the modulation of the immune response by parasites to prolong tablished a clear age-related resistance to (re)infection, with children being more susceptible than adults [1] . These studies their survival within their human host. In Kenya, studies of S. mansoni -infected persons have indicated that parasite-specific have also indicated that antigen-specific IgE and eosinophilia are associated with resistance to reinfection [2, 3] , implying IFN-g and IL-5 production is higher after clearance of infection [7] . Moreover, in Schistosoma haematobium -infected persons, that a bias toward Th2 might provide protection to invading parasites. Indeed, in persons with a resistant phenotype, Th0
we demonstrated that a decrease in egg output was associated clones with a high ratio of interleukin (IL)-4 to interferon with an increase in proliferation and IL-4 production at 5 weeks (IFN)-g seem to be predominant [4] . However, it has been after chemotherapy [8] . These data suggest that both Th1 and shown that persons exposed to schistosomes who remain free Th2 subsets are involved in the immune response to parasites from infection (the so-called endemic normals) produce high and may be down-modulated during active infection. levels of IFN-g in response to parasite antigens compared with
Here we have examined the cellular immune responses in infected subjects [5] . Recently, a major gene that determines persons previously infected, to similar levels, with S. haemathe intensity of Schistosoma mansoni infection was localized tobium, who are now uninfected or reinfected 2 years after on chromosome 5, containing genes encoding, among others, chemotherapy, to determine how immune responses are influTh2 cytokines and a region regulating IgE levels [6] .
enced by the long-term presence or absence of infection.
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Materials and Methods
Informed consent was obtained from all patients before clinical and parasitologic examination and blood withdrawal, and the study was approved by the Study population. The study took place in an area in which S. (who could be traced and were willing to participate) were exam- water contact, as recently described [9] . From the 57, we excluded
